Diasia Science and Technology Development Co., Ltd. Shenzhen is a high-tech enterprise founded in 2013, specializing in the research, development, and marketing of In Vitro Diagnostic (IVD) instruments and reagents. With over 201-300 employees, the company is deeply involved in PCR technology, hematology analysis, clinical chemistry, immunofluorescence, pathological staining, and rapid tests. They are recognized for developing various Point-of-Care Testing (POCT) machines and a self-developed intelligent medical data management system. Their product portfolio includes Dry Chemistry Analyzers, Urine Analyzers, Fluorescence immunoassay (FIA) Analyzers, WBC Analyzers, and Real-time PCR Systems, as well as COVID-19 antigen, antibody, and PCR tests. Diasia Science and Technology Development Co., Ltd. Shenzhen holds ISO 13485, CE, and FDA certifications, and operates a factory. The company exports its products to over 30 countries and regions globally, serving a diverse user base including large and medium-sized hospitals, CDCs, and blood centers. They also engage in contract manufacturing and collaborate with international biotech companies.
Food Safety Rapid Test Strips for Nitrate$16.7
Food Safety Rapid Test Strips for Protein in Milk$21.9
Food Safety Rapid Test Strips for Cyanide$31.3
Food Safety Rapid Test Strips for Nitrite$15.7
Food Safety Rapid Test Strips for Alcohol$42.9
Food Safety Rapid Test Strips for Surface Hygiene$24.6
Food Safety Rapid Test Strips for Pesticide$26.2
Food Safety Rapid Test Strips for Nitrate and Nitrite$23.8
Food Safety Rapid Test Strips for Glucose$25
Food Safety Rapid Test Strips for Arsenic$39.1
Shenzhen New Industries Biomedical Engineering Co., Ltd
🇨🇳 China
19952001-5000 peopleManufacturer
High capacity factory
Established brand
Large enterprise group
High-tech enterprise
Shipments
43938
Key customer
SNIBE DIAGNOSTIC
Key market
🇮🇳 India
Description
Shenzhen New Industries Biomedical Engineering Co., Ltd. (SNIBE), established in December 1995, is a national high-tech enterprise and manufacturer based in Shenzhen, China. With a workforce of 2,001 to 5,000 employees, SNIBE specializes in the R&D, production, sales, and service of in-vitro diagnostic products, with a primary focus on chemiluminescence immunoassay. The company operates a factory and offers OEM services. SNIBE provides a comprehensive range of clinical laboratory instruments and in-vitro diagnostic reagents, including immunoassay analyzers (e.g., MAGLUMI X series), biochemistry analyzers (e.g., Biossays C series), coagulation analyzers (e.g., Hemolumi H6), and electrolyte analyzers (Biossays E6 Plus). They also offer integrated laboratory solutions such as the SATLARS T8 fully automated intelligent assembly line and molecular diagnostic analyzers. SNIBE holds numerous certifications, including ISO 9001, ISO 13485, CE, EMC DIRECTIVE, and FSC, along with FDA clearance and CE List A for various assays. Their products are utilized in over 160 countries and regions globally, with over 30,000 fully automatic chemiluminescence analyzers installed worldwide.